Vosselaar, Belgium

Thomas Joachim Landewald Rammeloo

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignee: Janssen Pharmaceutica Nv. Active years: 2012-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Joachim Landewald Rammeloo. Retrieved from https://idiyas.com/inventor/thomas-joachim-landewald-rammeloo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Vosselaar, BE (2012 - 2014)
  • Beerse, BE (2019)

Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Thomas Joachim Landewald Rammeloo.

Introduction

Thomas Joachim Landewald Rammeloo, an accomplished inventor based in Vosselaar, Belgium, has made significant contributions to the field of pharmacological crystallization. With a total of three patents to his name, Rammeloo is recognized for his innovative approaches in improving the crystallization processes of various compounds.

Latest Patents

Among his latest patents are two remarkable inventions. The first patent is a crystallization procedure for obtaining canagliflozin hemihydrate crystals. This invention proposes an improved method that allows for narrow particle size distribution by strategically removing a small part of the crystalline suspension from the crystallization vessel. This portion is subject to particle size reduction, followed by heating before being reintroduced into the vessel, which operates within a specific temperature range.

The second patent focuses on the crystallization process for 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl] benzene. This procedure yields hemihydrate crystals characterized by improved flowability, as well as enhanced bulk and tap density properties, thereby addressing critical criteria in pharmaceutical formulations.

Career Highlights

Rammeloo is associated with Janssen Pharmaceutica NV, a leading pharmaceutical company dedicated to developing innovative solutions for healthcare. His work within the organization has enabled him to push the boundaries of crystallization technology, resulting in advanced methodologies that significantly benefit drug formulation processes.

Collaborations

In his quest for innovation, Rammeloo collaborates with talented individuals such as Ruben De Keyser and Stijn Laps. Together, they work to refine processes and create innovative solutions within the field of pharmaceuticals, demonstrating the importance of teamwork in achieving breakthrough advancements.

Conclusion

Thomas Joachim Landewald Rammeloo's contributions to crystallization processes have the potential to enhance pharmaceutical formulations significantly. With a solid foundation of patents, innovative methodologies, and collaborative efforts, Rammeloo continues to exemplify the spirit of innovation in the realm of pharmaceuticals. His work not only advances scientific understanding but also improves health outcomes for patients around the globe.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…